1. OC-0319: Validation of a companion diagnostic biomarker for prospective use in prostate radiotherapy trials. (November 2020) Authors: Thiruthaneeswaran, N.; Bibby, B.A.S.; Pereira, R.; More, E.; Bristow, R.G.; Choudhury, A.; West, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. (November 2020) Authors: Thiruthaneeswaran, N.; Bibby, B.A.S.; Pereira, R.; More, E.; Denley, H.; Henry, A.; Wylie, J.; Hoskin, P.; Bristow, R.; Choudhury, A.; West, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗